NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email As tariffs loomed this spring, PYMNTS Intelligence found that obtaining financing was (and is) a difficult endeavor for smaller firms, which power theRead More
